Two major contributors to reduced health-related quality of life (HRQoL) in patients with chronic lymphocytic leukemia (CLL) and lymphoma are muscle weakness and fatigue, according to a study ...

Now, new research suggests that they do more than just benefiting your heart, they also mitigate the risk of cancer. Recently ...

Dizal (SSE:688192), a biopharmaceutical company committed to developing novel medicines for the treatment of cancer and ...

Statin therapy potentially reduces cancer mortality risk by 60%, a new study indicates. LONDON, April 24: ...

Studies have shown that using statin drugs used to treat hyperlipidemia as a combination therapy can reduce the risk of ...